ARCHIVES

FDA Approves Abraxane And Alimta for NSCLC

This article is from The Cancer Letter archive.

Vol. 35 No. 10 | October 26, 2012

Download PDF Visit The Full Archive

Related Articles

DCBDC To Contract For CA Agents In Vaccine Testing

November 15, 1991

Trial: Decitabine Improves Survival in Myeloid Leukemia

July 29, 2011

MIT Researcher Ingested P-32; NRC Investigating

October 27, 1995

PhRMA Tightens DTC Restrictions, But Dingell Says It’s Not Enough.

December 12, 2008

Funding Opportunities (8-page issue).

May 23, 2003

FDA News: Avastin Combination Approved In Recurrent Ovarian Cancer

November 14, 2014